EWA
ARKG icon

ERTS Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

ERTS Wealth Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-200
Closed -$5K – 106
2018
Q4 		$5K Buy
+200
New +$5.64K ﹤0.01% 269

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
BCM
Barometer Capital Management Toronto, Ontario, Canada $360M AUM 83.37% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $4.23B AUM 29.95% 1-Year Est. Return

ERTS Wealth Advisors's ARKG Position: Q1 2019 in Review

ERTS Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2019, closing a stake of 200 shares — an estimated $5K sold.

ERTS Wealth Advisors first reported a position in ARKG in Q4 2018 and held it in 1 quarter. The position peaked at $5K in Q4 2018. 64 funds tracked by Wall St. Rank hold ARKG as of Q1 2019.

  • ERTS Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2019 after selling out during the quarter.
  • ERTS Wealth Advisors sold 200 ARK Genomic Revolution ETF shares in Q1 2019, an estimated $5K.
  • ERTS Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2018 and held it in 1 quarter.
  • ERTS Wealth Advisors's ARK Genomic Revolution ETF position peaked at $5K in Q4 2018.
  • 64 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2019.

Based on ERTS Wealth Advisors's 13F filing for Q1 2019, filed 15 May 2019.